@daxiongmao
Olin Biologics announced that it has received a Clinical Trial Approval Notice from the National Medical Products Administration regarding the quadrivalent influenza virus split vaccine, agreeing to conduct clinical trials related to the prevention of influenza related types in populations aged 6 months and above.